Back
Day Range
$137.92
$140.42
52-Week Range
$93.37
$157.29
Volume
5,052,129
50D / 200D Avg
$141.92
/
$123.02
Prev Close
$138.11
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 20.2 | 0.3 |
| P/B | 7.6 | 3.0 |
| ROE % | 40.6 | 3.7 |
| Net Margin % | 28.9 | 3.8 |
| Rev Growth 5Y % | 1.9 | 10.0 |
| D/E | 1.1 | 0.2 |
Analyst Price Target
Hold
$158.71
+14.8%
Low: $105.00
High: $180.00
Forward P/E
15.93
Forward EPS
$8.68
EPS Growth (est.)
+0.0%
Est. Revenue
30.22B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$12.67
$12.21 – $13.25
|
37.70B | 6 |
| FY2029 |
$11.68
$11.26 – $12.22
|
35.81B | 6 |
| FY2028 |
$10.50
$8.62 – $11.85
|
33.75B | 8 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-10 | $1.81 | $1.86 | +2.8% |
| 2025-10-30 | $2.13 | $2.47 | +16.0% |
| 2025-08-07 | $1.96 | $2.01 | +2.6% |
| 2025-04-24 | $1.78 | $1.81 | +1.7% |
| 2025-02-11 | $1.74 | $1.90 | +9.2% |
| 2024-11-06 | $1.53 | $2.02 | +32.0% |
| 2024-08-08 | $1.61 | $2.01 | +24.8% |
| 2024-04-25 | -$1.49 | -$1.32 | +11.4% |
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 |
Mercier Johanna
Chief Comm & Corp Aff Officer
|
sell | 3,000 | $144.23 | $432,690.00 |
| Mar 16, 2026 |
Dickinson Andrew D
Chief Financial Officer
|
sell | 3,000 | $144.23 | $432,690.00 |
| Feb 27, 2026 |
Berger Dietmar
Chief Medical Officer
|
grant | 8,530 | — | — |
| Feb 27, 2026 |
Cain Wettan Keeley M
EVP Gen Counsel, Legal & Comp
|
grant | 470 | — | — |
| Jan 20, 2026 |
Bluestone Jeffrey
Director
|
other | 10,000 | $67.45 | — |
| Jan 20, 2026 |
Bluestone Jeffrey
Director
|
sell | 5,000 | $123.50 | $617,500.00 |
| Dec 29, 2025 |
O'Day Daniel Patrick
Chairman & CEO
|
sell | 10,000 | $124.83 | $1,248,272.00 |
| Dec 15, 2025 |
Dickinson Andrew D
Chief Financial Officer
|
sell | 3,000 | $122.00 | $366,000.00 |
| Nov 28, 2025 |
Bluestone Jeffrey
Director
|
other | 10,000 | $64.92 | — |
| Nov 28, 2025 |
Bluestone Jeffrey
Director
|
sell | 5,000 | $125.08 | $625,400.00 |
| Nov 17, 2025 |
Dickinson Andrew D
Chief Financial Officer
|
sell | 2,500 | $125.23 | $313,075.00 |
| Oct 15, 2025 |
Dickinson Andrew D
Chief Financial Officer
|
sell | 2,500 | $118.08 | $295,200.00 |
| Sep 15, 2025 |
Mercier Johanna
Chief Commercial Officer
|
sell | 3,000 | $113.57 | $340,710.00 |
| Sep 10, 2025 |
Mercier Johanna
Chief Commercial Officer
|
other | 9,507 | — | — |
| Jul 15, 2025 |
Mercier Johanna
Chief Commercial Officer
|
sell | 3,000 | $111.03 | $333,090.00 |
| Jun 16, 2025 |
Dickinson Andrew D
Chief Financial Officer
|
sell | 2,500 | $110.17 | $275,425.00 |
| Jun 10, 2025 |
Telman Deborah H
EVP, Corporate Affairs & GC
|
other | 3,056 | — | — |
| Jun 10, 2025 |
Wilfong Diane E.
Interim Corp Controller & CAO
|
other | 2,180 | — | — |
| Jun 10, 2025 |
Dickinson Andrew D
Chief Financial Officer
|
other | 9,146 | — | — |
| May 15, 2025 |
Dickinson Andrew D
Chief Financial Officer
|
sell | 2,500 | $99.82 | $249,550.00 |
Dividend History
7 yr streakYield
0.03%
Payout Ratio
0.47%
Growth (3Y)
2.67%
Growth (5Y)
3.04%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 13, 2026 | Mar 30, 2026 | $0.82 | 2.20% |
| Dec 15, 2025 | Dec 30, 2025 | $0.79 | 2.64% |
| Sep 15, 2025 | Sep 29, 2025 | $0.79 | 2.79% |
| Jun 13, 2025 | Jun 27, 2025 | $0.79 | 2.84% |
| Mar 14, 2025 | Mar 28, 2025 | $0.79 | 2.78% |
| Dec 13, 2024 | Dec 30, 2024 | $0.77 | 3.35% |
| Sep 13, 2024 | Sep 27, 2024 | $0.77 | 3.70% |
| Jun 14, 2024 | Jun 27, 2024 | $0.77 | 4.67% |
| Mar 14, 2024 | Mar 28, 2024 | $0.77 | 4.07% |
| Dec 14, 2023 | Dec 28, 2023 | $0.75 | 3.67% |
| Sep 14, 2023 | Sep 28, 2023 | $0.75 | 3.85% |
| Jun 14, 2023 | Jun 29, 2023 | $0.75 | 3.80% |
| Mar 14, 2023 | Mar 30, 2023 | $0.75 | 3.69% |
| Dec 14, 2022 | Dec 29, 2022 | $0.73 | 3.30% |
| Sep 14, 2022 | Sep 29, 2022 | $0.73 | 4.45% |
| Jun 14, 2022 | Jun 29, 2022 | $0.73 | 4.98% |
| Mar 14, 2022 | Mar 30, 2022 | $0.73 | 4.92% |
| Dec 14, 2021 | Dec 30, 2021 | $0.71 | 4.03% |
| Sep 14, 2021 | Sep 29, 2021 | $0.71 | 3.99% |
| Jun 14, 2021 | Jun 29, 2021 | $0.71 | 4.08% |
Key Takeaways
Revenue grew 1.90% annually over 5 years — modest growth
Earnings grew 1672.92% over the past year
ROE of 40.57% indicates high profitability
Net margin of 28.90% shows strong profitability
Generating 9.46B in free cash flow
PEG of 0.01 suggests growth is underpriced
Growth
Revenue Growth (5Y)
1.90%
Revenue (1Y)2.40%
Earnings (1Y)1672.92%
FCF Growth (3Y)12.88%
Quality
Return on Equity
40.57%
ROIC18.77%
Net Margin28.90%
Op. Margin40.14%
Safety
Debt / Equity
1.09
Current Ratio1.68
Interest Coverage11.54
Valuation
P/E Ratio
20.17
Forward P/E15.93
P/B Ratio7.59
EV/EBITDA15.97
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.40% | Revenue Growth (3Y) | 4.20% |
| Earnings Growth (1Y) | 1672.92% | Earnings Growth (3Y) | 22.56% |
| Revenue Growth (5Y) | 1.90% | Earnings Growth (5Y) | 8.13% |
| Profitability | |||
| Revenue (TTM) | 29.44B | Net Income (TTM) | 8.51B |
| ROE | 40.57% | ROA | 14.42% |
| Gross Margin | 86.69% | Operating Margin | 40.14% |
| Net Margin | 28.90% | Free Cash Flow (TTM) | 9.46B |
| ROIC | 18.77% | FCF Growth (3Y) | 12.88% |
| Safety | |||
| Debt / Equity | 1.09 | Current Ratio | 1.68 |
| Interest Coverage | 11.54 | ||
| Dividends | |||
| Dividend Yield | 0.03% | Payout Ratio | 0.47% |
| Dividend Growth (3Y) | 2.67% | Dividend Growth (5Y) | 3.04% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 20.17 | Forward P/E | 15.93 |
| P/B Ratio | 7.59 | P/S Ratio | 5.83 |
| PEG Ratio | 0.01 | Forward PEG | N/A |
| EV/EBITDA | 15.97 | Fwd EV/EBITDA | 18.94 |
| Forward P/S | 5.68 | Fwd Earnings Yield | 6.28% |
| FCF Yield | 5.51% | ||
| Market Cap | 171.64B | Enterprise Value | 188.67B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 29.44B | 28.75B | 27.12B | 27.28B | 27.31B |
| Net Income | 8.51B | 480.00M | 5.67B | 4.59B | 6.23B |
| EPS (Diluted) | 6.78 | 0.38 | 4.50 | 3.64 | 4.93 |
| Gross Profit | 25.52B | 22.50B | 20.62B | 21.62B | 20.70B |
| Operating Income | 11.82B | 1.66B | 7.61B | 7.33B | 9.92B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 59.02B | 59.00B | 62.13B | 63.17B | 67.95B |
| Total Liabilities | 36.41B | 39.75B | 39.38B | 41.96B | 46.89B |
| Shareholders' Equity | 22.62B | 19.33B | 22.83B | 21.24B | 21.07B |
| Total Debt | 24.59B | 26.71B | 24.99B | 25.23B | 26.70B |
| Cash & Equivalents | 7.56B | 9.99B | 6.09B | 5.41B | 5.34B |
| Current Assets | 19.89B | 19.17B | 16.09B | 14.44B | 14.77B |
| Current Liabilities | 11.81B | 12.00B | 11.28B | 11.24B | 11.61B |